BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esnault VL, Testa A, Audrain M, Rogé C, Hamidou M, Barrier JH, Sesboüé R, Martin J, Lesavre P. Alpha1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney International 1993;43:1329-32. [DOI: 10.1038/ki.1993.186] [Cited by in Crossref: 138] [Cited by in F6Publishing: 118] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 2004;59:441-5. [PMID: 15115878 DOI: 10.1136/thx.2003.006510] [Cited by in Crossref: 96] [Cited by in F6Publishing: 80] [Article Influence: 5.6] [Reference Citation Analysis]
2 Williams J, Kamesh L, Savage C. Translating basic science into patient therapy for ANCA-associated small vessel vasculitis. Clinical Science 2005;108:101-12. [DOI: 10.1042/cs20040232] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
3 Stoller JK, Tomashefski J, Crystal RG, Arroliga A, Strange C, Killian DN, Schluchter MD, Wiedemann HP. Mortality in Individuals With Severe Deficiency of α1-Antitrypsin. Chest 2005;127:1196-204. [DOI: 10.1016/s0012-3692(15)34467-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Fieschi C, Rasura M, Anzini A, Beccia M. Central nervous system vasculitis. J Neurol Sci 1998;153:159-71. [PMID: 9511875 DOI: 10.1016/s0022-510x(97)00288-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
5 Tarzi RM, Cook HT, Pusey CD. Crescentic Glomerulonephritis: New Aspects of Pathogenesis. Seminars in Nephrology 2011;31:361-8. [DOI: 10.1016/j.semnephrol.2011.06.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
6 Russo AJ, Krigsman A, Jepson B, Wakefield A. Low Serum Alpha-Antitrypsin Associated with Anti-PR-3 ANCA in Autistic Children with GI Disease. Genomics Insights 2009;2:1-9. [PMID: 26244018 DOI: 10.4137/gei.s2918] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
7 Savage COS, Harper L, Holland M. New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis: . Current Opinion in Rheumatology 2002;14:15-22. [DOI: 10.1097/00002281-200201000-00004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 3.2] [Reference Citation Analysis]
8 Korkmaz B, Jenne DE, Gauthier F. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases. Int Immunopharmacol 2013;17:1198-205. [PMID: 23886601 DOI: 10.1016/j.intimp.2013.07.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
9 Mota A, Sahebghadam Lotfi A, Jamshidi AR, Najavand S. Alpha 1-antitrypsin activity is markedly decreased in Wegener's granulomatosis. Rheumatol Int 2014;34:553-8. [PMID: 23604680 DOI: 10.1007/s00296-013-2745-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jagiello P, Wieczorek S, Yu P, Csernok E, Gross WL, Epplen JT. Association study with Wegener granulomatosis of the human phospholipase Cgamma2 gene. J Negat Results Biomed 2005;4:1. [PMID: 15703080 DOI: 10.1186/1477-5751-4-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 Sandhaus R, Strange C, Stone G, Runken MC, Blanchette CM, Howden R. Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US. Int J Chron Obstruct Pulmon Dis 2020;15:2389-97. [PMID: 33116454 DOI: 10.2147/COPD.S263297] [Reference Citation Analysis]
12 Callea F, Francalanci P, Giovannoni I. Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases. Int J Mol Sci 2021;22:5778. [PMID: 34071368 DOI: 10.3390/ijms22115778] [Reference Citation Analysis]
13 Kelly E, Greene CM, Carroll TP, McElvaney NG, O’Neill SJ. Alpha-1 antitrypsin deficiency. Respir Med. 2010;104:763-772. [PMID: 20303723 DOI: 10.1016/j.rmed.2010.01.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
14 Lock Wood CM. New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy. Clinical & Experimental Immunology 1996;104:77-82. [DOI: 10.1111/cei.1996.104.s1.77] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 15.5] [Reference Citation Analysis]
15 Schievink WI, Puumala MR, Meyer FB, Raffel C, Katzmann JA, Parisi JE. Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with α1-antitrypsin deficiency: Case report. Journal of Neurosurgery 1996;85:503-6. [DOI: 10.3171/jns.1996.85.3.0503] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
16 American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168:818-900. [PMID: 14522813 DOI: 10.1164/rccm.168.7.818] [Cited by in Crossref: 612] [Cited by in F6Publishing: 490] [Article Influence: 43.7] [Reference Citation Analysis]
17 Halbwachs L, Lesavre P. Endothelium-neutrophil interactions in ANCA-associated diseases. J Am Soc Nephrol 2012;23:1449-61. [PMID: 22942199 DOI: 10.1681/ASN.2012020119] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 5.9] [Reference Citation Analysis]
18 Gencik M, Borgmann S, Zahn R, Albert E, Sitter T, Epplen JT, Fricke H. Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1999;117:412-7. [PMID: 10444278 DOI: 10.1046/j.1365-2249.1999.00969.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.0] [Reference Citation Analysis]
19 Craig TJ, Henao MP. Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder. Allergy 2018;73:2110-21. [PMID: 29984428 DOI: 10.1111/all.13558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
20 Segelmark M, Elzouki A, Wieslander J, Eriksson S. The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney International 1995;48:844-50. [DOI: 10.1038/ki.1995.360] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 3.7] [Reference Citation Analysis]
21 Hatipoğlu U, Stoller JK. α1-Antitrypsin Deficiency. Clin Chest Med 2016;37:487-504. [PMID: 27514595 DOI: 10.1016/j.ccm.2016.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
22 Bergin DA, Hurley K, McElvaney NG, Reeves EP. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp (Warsz). 2012;60:81-97. [PMID: 22349104 DOI: 10.1007/s00005-012-0162-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
23 Schonfeld EA, Brown RS Jr. Genetic Causes of Liver Disease: When to Suspect a Genetic Etiology, Initial Lab Testing, and the Basics of Management. Med Clin North Am 2019;103:991-1003. [PMID: 31582009 DOI: 10.1016/j.mcna.2019.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Reumaux D, Duthilleul P, Roos D. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. Human Immunology 2004;65:1-12. [DOI: 10.1016/j.humimm.2003.09.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
25 Gooptu B, Lomas DA. Polymers and inflammation: disease mechanisms of the serpinopathies. J Exp Med 2008;205:1529-34. [PMID: 18591408 DOI: 10.1084/jem.20072080] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
26 Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000;57:846-62. [PMID: 10720938 DOI: 10.1046/j.1523-1755.2000.057003846.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 113] [Article Influence: 7.1] [Reference Citation Analysis]
27 Xiao H, Ciavatta D, Aylor DL, Hu P, de Villena FP, Falk RJ, Jennette JC. Genetically determined severity of anti-myeloperoxidase glomerulonephritis. Am J Pathol 2013;182:1219-26. [PMID: 23384999 DOI: 10.1016/j.ajpath.2012.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
28 Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365:2225-2236. [PMID: 15978931 DOI: 10.1016/s0140-6736(05)66781-5] [Cited by in Crossref: 386] [Cited by in F6Publishing: 124] [Article Influence: 24.1] [Reference Citation Analysis]
29 Hazari YM, Bashir A, Habib M, Bashir S, Habib H, Qasim MA, Shah NN, Haq E, Teckman J, Fazili KM. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions. Mutat Res. 2017;773:14-25. [PMID: 28927525 DOI: 10.1016/j.mrrev.2017.03.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
30 Ludvigsson JF, Inghammar M, Ekberg M, Egesten A. A nationwide cohort study of the risk of chronic obstructive pulmonary disease in coeliac disease: COPD in CD. Journal of Internal Medicine 2012;271:481-9. [DOI: 10.1111/j.1365-2796.2011.02448.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
31 Meier P, Dayer E, Lemoine R, Blanc E. Henoch‐Schönlein purpura with IgG PR3‐ANCA in a PiZZ alpha 1‐antitrypsin deficient patient. Nephrology Dialysis Transplantation 2001;16:1932-5. [DOI: 10.1093/ndt/16.9.1932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
32 Sreih AG, Mandhadi R, Aldaghlawi F, Khan A, Irshad V, Finn K, Block JA. ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity. Clin Rheumatol 2015;34:943-8. [PMID: 24752347 DOI: 10.1007/s10067-014-2617-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
33 Ioachimescu OC, Stoller JK. A Review of Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 2009;2:263-75. [DOI: 10.1081/copd-57602] [Cited by in Crossref: 23] [Article Influence: 1.9] [Reference Citation Analysis]
34 Korkmaz B, Lesner A, Letast S, Mahdi YK, Jourdan M, Dallet-choisy S, Marchand-adam S, Kellenberger C, Viaud-massuard M, Jenne DE, Gauthier F. Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis). Semin Immunopathol 2013;35:411-21. [DOI: 10.1007/s00281-013-0362-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
35 Theprungsirikul J, Skopelja-Gardner S, Rigby WFC. Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions. J Transl Autoimmun 2021;4:100105. [PMID: 34142075 DOI: 10.1016/j.jtauto.2021.100105] [Reference Citation Analysis]
36 Hilhorst M, van Paassen P, Tervaert JW; Limburg Renal Registry. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis. J Am Soc Nephrol 2015;26:2314-27. [PMID: 25956510 DOI: 10.1681/ASN.2014090903] [Cited by in Crossref: 100] [Cited by in F6Publishing: 50] [Article Influence: 16.7] [Reference Citation Analysis]
37 Gregorini G, Tira P, Frizza J, D′haese PC, Elseviers MM, Nuyts G, Maiorca R, De Broe ME. ANCA-associated diseases and silica exposure. Clinic Rev Allerg Immunol 1997;15:21-40. [DOI: 10.1007/bf02828275] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
38 Henao MP, Craig TJ. Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency. Expert Rev Respir Med 2016;10:1281-94. [PMID: 27771979 DOI: 10.1080/17476348.2016.1249851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
39 Mahadeva R, Chang WS, Dafforn TR, Oakley DJ, Foreman RC, Calvin J, Wight DG, Lomas DA. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest 1999;103:999-1006. [PMID: 10194472 DOI: 10.1172/JCI4874] [Cited by in Crossref: 132] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
40 Morgan MD, Harper L, Williams J, Savage C. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol 2006;17:1224-34. [PMID: 16624931 DOI: 10.1681/ASN.2005080882] [Cited by in Crossref: 90] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
41 Collins MP, Kissel JT. Neuropathies with Systemic Vasculitis. Peripheral Neuropathy. Elsevier; 2005. pp. 2335-404. [DOI: 10.1016/b978-0-7216-9491-7.50108-3] [Cited by in Crossref: 12] [Article Influence: 0.8] [Reference Citation Analysis]
42 Pagnoux C, Teixeira L. Granulomatose de Wegener. La Presse Médicale 2007;36:860-74. [DOI: 10.1016/j.lpm.2007.02.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
43 Moxey JM, Low EV, Turner AM. Rare case of eosinophilic granulomatosis with polyangiitis in two patients with α-1-antitrypsin deficiency (PiSZ). BMJ Case Rep 2016;2016:bcr2015214118. [PMID: 27118743 DOI: 10.1136/bcr-2015-214118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
44 Esnault VL, Moreau A, Testa A, Besnier D. Glomérulonéphrites extracapillaires. Néphrologie & Thérapeutique 2006;2:446-60. [DOI: 10.1016/j.nephro.2006.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
45 Elzouki AY, Segelmark M, Wieslander J, Eriksson S. Strong link between the alpha 1 -antitrypsin PiZ allele and Wegener's granulomatosis. Journal of Internal Medicine 1994;236:543-8. [DOI: 10.1111/j.1365-2796.1994.tb00842.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 3.0] [Reference Citation Analysis]
46 Harper L, Savage CO. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000;190:349-59. [PMID: 10685069 DOI: 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A] [Cited by in Crossref: 97] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
47 Mahadeva R, Dunn AC, Westerbeek RC, Sharples L, Whitehouse DB, Carroll NR, Ross-Russell RI, Webb AK, Bilton D, Lomas DA, Lockwood CM. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol 1999;117:561-7. [PMID: 10469063 DOI: 10.1046/j.1365-2249.1999.01006.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
48 Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010;62:726-59. [PMID: 21079042 DOI: 10.1124/pr.110.002733] [Cited by in Crossref: 447] [Cited by in F6Publishing: 441] [Article Influence: 44.7] [Reference Citation Analysis]
49 Bergin DA, Reeves EP, Hurley K, Wolfe R, Jameel R, Fitzgerald S, McElvaney NG. The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci Transl Med 2014;6:217ra1. [PMID: 24382893 DOI: 10.1126/scitranslmed.3007116] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 11.3] [Reference Citation Analysis]
50 Burns A. Pulmonary vasculitis. Thorax 1998;53:220-7. [PMID: 9659360 DOI: 10.1136/thx.53.3.220] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
51 Savage CO, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8. [PMID: 9048802 DOI: 10.1016/s0140-6736(97)80118-3] [Cited by in Crossref: 130] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
52 Cattan S, Mariette X, Labrousse F, Brouet J. Iliac artery dissection in α1-antitrypsin deficiency. The Lancet 1994;343:1371-2. [DOI: 10.1016/s0140-6736(94)92513-5] [Cited by in Crossref: 25] [Article Influence: 0.9] [Reference Citation Analysis]
53 Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185:246-259. [PMID: 21960536 DOI: 10.1164/rccm.201108-1428CI] [Cited by in Crossref: 253] [Cited by in F6Publishing: 113] [Article Influence: 25.3] [Reference Citation Analysis]
54 Kawasaki A, Tsuchiya N. Advances in the genomics of ANCA-associated vasculitis-a view from East Asia. Genes Immun 2021;22:1-11. [PMID: 33686257 DOI: 10.1038/s41435-021-00123-x] [Reference Citation Analysis]
55 Wu W, Chaer RA. Nonarteriosclerotic vascular disease. Surg Clin North Am 2013;93:833-75, viii. [PMID: 23885934 DOI: 10.1016/j.suc.2013.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
56 Summ O, Gregor N, Marziniak M, Gralow I, Husstedt IW, Evers S. Cluster headache and Alpha 1-antitrypsin deficiency. Cephalalgia 2010;30:113-7. [PMID: 19515129 DOI: 10.1111/j.1468-2982.2009.01897.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
57 Banerjee P, Jain A, Kumar U, Senapati S. Epidemiology and genetics of granulomatosis with polyangiitis. Rheumatol Int 2021;41:2069-89. [PMID: 34635927 DOI: 10.1007/s00296-021-05011-1] [Reference Citation Analysis]
58 Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214-223. [PMID: 22808956 DOI: 10.1056/nejmoa1108735] [Cited by in Crossref: 571] [Cited by in F6Publishing: 220] [Article Influence: 63.4] [Reference Citation Analysis]
59 Mohammad A, Segelmark M. Primary systemic vasculitis with severe α1-antitrypsin deficiency revisited. Scand J Rheumatol 2014;43:242-5. [PMID: 24313382 DOI: 10.3109/03009742.2013.846405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
60 Griffith M, Brett S. The pulmonary physician in critical care * illustrative case 3: pulmonary vasculitis. Thorax 2003;58:543-6. [PMID: 12775874 DOI: 10.1136/thorax.58.6.543] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
61 Crossley D, Stockley R, Sapey E. Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease? Drugs Aging 2019;36:823-40. [PMID: 31179525 DOI: 10.1007/s40266-019-00684-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
62 Brachemi S, Mambole A, Fakhouri F, Mouthon L, Guillevin L, Lesavre P, Halbwachs-Mecarelli L. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies. J Am Soc Nephrol 2007;18:2330-9. [PMID: 17634439 DOI: 10.1681/ASN.2006121309] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
63 Luqmani RA, Robinson H. Introduction to, and classification of, the systemic vasculitides. Best Pract Res Clin Rheumatol 2001;15:187-202. [PMID: 11469817 DOI: 10.1053/berh.2001.0139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
64 Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 1997;100:1416-24. [PMID: 9294107 DOI: 10.1172/JCI119662] [Cited by in Crossref: 129] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
65 Rooney CP, Taggart C, Coakley R, Mcelvaney NG, O'neill SJ. Anti–Proteinase 3 Antibody Activation of Neutrophils Can Be Inhibited by α 1-Antitrypsin. Am J Respir Cell Mol Biol 2001;24:747-54. [DOI: 10.1165/ajrcmb.24.6.4147] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
66 Hogan G, Geoghegan P, Carroll TP, Clarke J, McElvaney OF, McElvaney OJ, McElvaney NG, Curley GF. α1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome? Anesthesiology 2021;134:792-808. [PMID: 33721888 DOI: 10.1097/ALN.0000000000003727] [Reference Citation Analysis]
67 Berndt A, Leme AS, Shapiro SD. Emerging genetics of COPD. EMBO Mol Med 2012;4:1144-55. [PMID: 23090857 DOI: 10.1002/emmm.201100627] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
68 Gencik M, Meller S, Borgmann S, Fricke H. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 2000;58:2473-7. [PMID: 11115080 DOI: 10.1046/j.1523-1755.2000.00430.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
69 Szyld P, Jagiello P, Csernok E, Gross WL, Epplen JT. On the Wegener granulomatosis associated region on chromosome 6p21.3. BMC Med Genet 2006;7:21. [PMID: 16526951 DOI: 10.1186/1471-2350-7-21] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
70 Beaudreuil S, Lasfargues G, Lauériere L, Ghoul ZE, Fourquet F, Longuet C, Halimi J, Nivet H, Büchler M. Occupational exposure in ANCA-positive patients: A case-control study. Kidney International 2005;67:1961-6. [DOI: 10.1111/j.1523-1755.2005.00295.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
71 Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, Tervaert JW. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000;57:2195-2206. [PMID: 10844589 DOI: 10.1046/j.1523-1755.2000.00080.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 133] [Article Influence: 7.4] [Reference Citation Analysis]
72 Kelly E, Greene CM, Carroll TP, Mcelvaney NG, O’neill SJ. Alpha-1 antitrypsin deficiency. Respiratory Medicine CME 2011;4:1-8. [DOI: 10.1016/j.rmedc.2011.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
73 Deshayes S, Martin Silva N, Grandhomme F, Khoy K, Mariotte D, Boutemy J, Maigné G, Brière-Bellier C, Delmas C, Bienvenu B, Lobbedez T, de Boysson H, Aouba A. Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort. J Rheumatol 2019;46:1502-8. [PMID: 30824651 DOI: 10.3899/jrheum.180591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Kohn R, Margolis ML. Localized Pulmonary Densities in a Patient with α1-Antitrypsin Deficiency. Ann Am Thorac Soc 2015;12:940-4. [PMID: 26075555 DOI: 10.1513/AnnalsATS.201411-509CC] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Renaudineau Y, Le Meur Y. Renal involvement in Wegener's granulomatosis. Clin Rev Allergy Immunol 2008;35:22-9. [PMID: 18172777 DOI: 10.1007/s12016-007-8066-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
76 Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism. Clin Exp Immunol 2006;145:63-70. [PMID: 16792675 DOI: 10.1111/j.1365-2249.2006.03119.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
77 Beauvillain C, Delneste Y, Renier G, Jeannin P, Subra JF, Chevailler A. Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them? Clin Rev Allergy Immunol 2008;35:47-58. [PMID: 18176846 DOI: 10.1007/s12016-007-8071-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
78 Mahr AD, Edberg JC, Stone JH, Hoffman GS, St Clair EW, Specks U, Dellaripa PF, Seo P, Spiera RF, Rouhani FN, Brantly ML, Merkel PA. Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis. Arthritis Rheum 2010;62:3760-7. [PMID: 20827781 DOI: 10.1002/art.27742] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
79 Hernández Pérez JM, Fumero García S, Alvarez Pío A. Successful α1-antitrypsin replacement therapy in a patient with α1-antitrypsin deficiency and granulomatosis with polyangiitis. Rheumatology (Oxford) 2013;52:755-7. [PMID: 22923761 DOI: 10.1093/rheumatology/kes233] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
80 Borgmann S, Endisch G, Urban S, Sitter T, Fricke H. A Linkage Disequilibrium between Genes at the Serine Protease Inhibitor Gene Cluster on Chromosome 14q32.1 Is Associated with Wegener's Granulomatosis. Clinical Immunology 2001;98:244-8. [DOI: 10.1006/clim.2000.4962] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
81 Griffith ME, Gaskin G, Pusey CD. Classification, Pathogenesis, and Treatment of Systemic Vasculitis. Renal Failure 2009;18:785-802. [DOI: 10.3109/08860229609047707] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
82 Rarok AA, Limburg PC, Kallenberg CGM. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. Journal of Leukocyte Biology 2003;74:3-15. [DOI: 10.1189/jlb.1202611] [Cited by in Crossref: 90] [Cited by in F6Publishing: 72] [Article Influence: 5.0] [Reference Citation Analysis]
83 Missen MA, Haylock D, Whitty G, Medcalf RL, Coughlin PB. Stage specific gene expression of serpins and their cognate proteases during myeloid differentiation. Br J Haematol 2006;135:715-24. [PMID: 17107353 DOI: 10.1111/j.1365-2141.2006.06360.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
84 Vignaud H, Cullin C, Bouchecareilh M. [Alpha-1 antitrypsin deficiency: A model of alteration of protein homeostasis or proteostasis]. Rev Mal Respir 2015;32:1059-71. [PMID: 26386628 DOI: 10.1016/j.rmr.2015.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
85 Birck R, Van Der Woude FJ. [Rapidly progressive glomerulonephritis:classification, pathogenesis and clinical management]. Internist (Berl) 2003;44:1107-19. [PMID: 14566464 DOI: 10.1007/s00108-003-1025-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
86 Xiao H. L9. The role of genetic background in an animal model of ANCA-associated vasculitis. Presse Med 2013;42:517-20. [PMID: 23465298 DOI: 10.1016/j.lpm.2013.01.009] [Reference Citation Analysis]
87 de Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW, Mahr AD, Niles JL, de Heer E, Bruijn JA, Bajema IM. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol 2008;3:237-52. [PMID: 18077783 DOI: 10.2215/CJN.03550807] [Cited by in Crossref: 67] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
88 Wieczorek S, Holle JU, Epplen JT. Recent progress in the genetics of Wegener's granulomatosis and Churg–Strauss syndrome. Current Opinion in Rheumatology 2010;22:8-14. [DOI: 10.1097/bor.0b013e3283331151] [Cited by in Crossref: 42] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
89 Lesavre P. The Diagnostic and Prognostic Significance of ANCA. Renal Failure 2009;18:803-12. [DOI: 10.3109/08860229609047708] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
90 Brogan PA. What's new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 2007;22:1083-94. [PMID: 17357785 DOI: 10.1007/s00467-007-0450-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
91 Wewers MD. Alpha1-antitrypsin deficiency: more than a protease imbalance? Chest 2004;125:1607-9. [PMID: 15136365 DOI: 10.1378/chest.125.5.1607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Abboud RT, Nelson TN, Jung B, Mattman A. Alpha1-antitrypsin deficiency: a clinical-genetic overview. Appl Clin Genet 2011;4:55-65. [PMID: 23776367 DOI: 10.2147/TACG.S10604] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
93 Tanna A, Salama AD, Brookes P, Pusey CD. Familial granulomatosis with polyangiitis: three cases of this rare disorder in one Indoasian family carrying an identical HLA DPB1 allele. BMJ Case Rep 2012;2012:bcr0120125502. [PMID: 23144337 DOI: 10.1136/bcr.01.2012.5502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
94 Schievink WI, Bjöurnsson J, Parisi JE, Prakash UB. Arterial Fibromuscular Dysplasia Associated With Severe α1-Antitrypsin Deficiency. Mayo Clinic Proceedings 1994;69:1040-3. [DOI: 10.1016/s0025-6196(12)61369-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
95 Savige JA, Chang L, Cook L, Burdon J, Daskalakis M, Doery J. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1995;100:194-7. [PMID: 7743654 DOI: 10.1111/j.1365-2249.1995.tb03652.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
96 Mccarthy C, Reeves EP, Mcelvaney NG. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency. Annals ATS 2016;13:S297-304. [DOI: 10.1513/annalsats.201509-634kv] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 5.6] [Reference Citation Analysis]
97 Eriksson S, Elzouki A. 4 α1-Antitrypsin deficiency. Baillière's Clinical Gastroenterology 1998;12:257-73. [DOI: 10.1016/s0950-3528(98)90134-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
98 Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med 2011;105:1129-39. [PMID: 21367592 DOI: 10.1016/j.rmed.2011.02.002] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 17.9] [Reference Citation Analysis]
99 Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, Stallone G, Castellano G, Gesualdo L. Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention. Front Med (Lausanne) 2020;7:582272. [PMID: 33738291 DOI: 10.3389/fmed.2020.582272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Schonfeld EA, Brown RS Jr. Genetic Testing in Liver Disease: What to Order, in Whom, and When. Clin Liver Dis 2017;21:673-86. [PMID: 28987255 DOI: 10.1016/j.cld.2017.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
101 Guilpain P, Chanseaud Y, Tamby M, Mahr A, Servettaz A, Guillevin L, Mouthon L. Pathogénie des vascularites systémiques primitives (I) : vascularites ANCA-positives. La Presse Médicale 2005;34:1013-22. [DOI: 10.1016/s0755-4982(05)84104-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
102 Lomas DA. Twenty Years of Polymers: A Personal Perspective on Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 2013;10:17-25. [DOI: 10.3109/15412555.2013.764401] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
103 Knight A, Sandin S, Askling J. Increased Risk of Autoimmune Disease in Families with Wegener’s Granulomatosis. J Rheumatol 2010;37:2553-8. [DOI: 10.3899/jrheum.091280] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
104 Ugarte-Gil MF, Espinoza LR. Genetics of ANCA-associated Vasculitides. Curr Rheumatol Rep 2014;16:428. [PMID: 24828480 DOI: 10.1007/s11926-014-0428-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
105 Salama AD. Pathogenesis and treatment of ANCA-associated systemic vasculitis. J R Soc Med 1999;92:456-61. [PMID: 10645294 DOI: 10.1177/014107689909200906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
106 Audrain MAP, Sesboüé R, Baranger TAR, Elliott J, Testa A, Martin J, Lockwood CM, Esnault VLM. Analysis of anti‐neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1‐antitrypsin‐deficient subjects. Nephrology Dialysis Transplantation 2001;16:39-44. [DOI: 10.1093/ndt/16.1.39] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
107 Korkmaz B, Moreau T, Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie 2008;90:227-42. [PMID: 18021746 DOI: 10.1016/j.biochi.2007.10.009] [Cited by in Crossref: 285] [Cited by in F6Publishing: 273] [Article Influence: 20.4] [Reference Citation Analysis]
108 Wieczorek S, Hoffjan S, Chan A, Rey L, Harper L, Fricke H, Holle JU, Gross WL, Epplen JT, Lamprecht P. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009;10:591-5. [PMID: 19536154 DOI: 10.1038/gene.2009.44] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
109 Inaty H, Arabelovic S. α1-Antitrypsin deficiency in a patient diagnosed with granulomatosis with polyangiitis. BMJ Case Rep 2013;2013:bcr2013009045. [PMID: 23625671 DOI: 10.1136/bcr-2013-009045] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
110 Greene CM, Low TB, O'Neill SJ, McElvaney NG. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. Am J Respir Crit Care Med 2010;181:31-5. [PMID: 19762563 DOI: 10.1164/rccm.200904-0545OC] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
111 Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis & Rheumatism 1998;41:1521-37. [DOI: 10.1002/1529-0131(199809)41:9<1521::aid-art2>3.0.co;2-a] [Cited by in Crossref: 278] [Cited by in F6Publishing: 58] [Article Influence: 12.1] [Reference Citation Analysis]
112 Schreiber A, Busjahn A, Luft FC, Kettritz R. Membrane Expression of Proteinase 3 Is Genetically Determined. JASN 2003;14:68-75. [DOI: 10.1097/01.asn.0000040751.83734.d1] [Cited by in Crossref: 108] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
113 Barnett VT, Sekosan M, Khurshid A. Wegener's Granulomatosis and α1-Antitrypsin-Deficiency Emphysema. Chest 1999;116:253-5. [DOI: 10.1378/chest.116.1.253] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
114 Muray Cases S, Alcázar Fajardo C, Cabezuelo Romero JB. Severe pulmonary emphysema in a young patient with vasculitis associated with proteinase-3 anti-neutrophil cytoplasmic antibodies (PR3-ANCA). Arch Bronconeumol 2018:S0300-2896(17)30438-6. [PMID: 29357994 DOI: 10.1016/j.arbres.2017.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
115 Holle JU, Wieczorek S, Gross WL. The Future of ANCA-associated Vasculitis. Rheumatic Disease Clinics of North America 2010;36:609-21. [DOI: 10.1016/j.rdc.2010.05.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
116 Lopes AP, Mineiro MA, Costa F, Gomes J, Santos C, Antunes C, Maia D, Melo R, Canotilho M, Magalhães E, Vicente I, Valente C, Gonçalves BG, Conde B, Guimarães C, Sousa C, Amado J, Brandão ME, Sucena M, Oliveira MJ, Seixas S, Teixeira V, Telo L. Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 2018;24 Suppl 1:1-21. [PMID: 30473034 DOI: 10.1016/j.pulmoe.2018.09.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
117 Lhotta K. Beyond hepatorenal syndrome: Glomerulonephritis in patients with liver disease. Seminars in Nephrology 2002;22:302-8. [DOI: 10.1053/snep.2002.33671] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]